Well-characterised preeclampsia biomarkers including fibronectin 1 (FN1)19,20 and complement factor D (CFD)21,22 were ~ twofold increased in abundance and among the most significant abundant proteins in both EOPE and LOPE, compared to control. This evidence concerns the gene CFD and preeclampsia.